MedTrace Logo

Stem Cells for Treating Critical Ischemia

NCT00488020 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2008-06-13

No results posted yet for this study

Summary

Collection of bone marrow blood Selection of mononuclear cells dilution with albumin injection into the calf muscles through 40 shots

Conditions

  • Critical Limb Ischemia
  • Ischemic Ulcers

Interventions

PROCEDURE

stem cells transplant

Sponsors & Collaborators

  • Instituto de Molestias Cardiovasculares

    lead OTHER

Principal Investigators

  • Jose D Araújo, MD · Instituto de Molestias Cardiovasculares

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Completion
2007-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00488020 on ClinicalTrials.gov